MedTrace Logo

Mood Effects of Serotonin Agonists Extended

NCT03934710 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2023-11-29

Study results available
· View outcomes & findings →

Summary

In this study we are examining the effects of repeated very low doses of serotonin agonists on mood individuals with negative mood.

Conditions

  • Healthy

Interventions

DRUG

Placebo

Drug will be administered in solution form

DRUG

Serotonin agonist - 13ug

13ug lysergic acid diethylamide

DRUG

Serotonin agonist - 26ug

26ug lysergic acid diethylamide

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of Chicago

    lead OTHER

Principal Investigators

  • Harriet de Wit · University of Chicago

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-20
Primary Completion
2021-06-07
Completion
2021-06-07
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03934710 on ClinicalTrials.gov